Bridgeway Capital Management, LLC Emergent Bio Solutions Inc. Transaction History

Bridgeway Capital Management, LLC

$4.24 Billion
Q4 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 72,500 shares of EBS stock, worth $558,975. This represents 0.02% of its overall portfolio holdings.

Number of Shares

72,500

Previous 112,500 35.56%

Holding current value

$558,975

Previous $939,000 26.2%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.72 - $11.97 $308,800 - $478,800	-40,000 Reduced 35.56%	72,500 $693,000
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $228,800 - $590,800	-40,000 Reduced 26.23%	112,500 $939,000
Q2 2024 Aug 14, 2024	SELL	$1.86 - $6.98 $817,345 - $3.07 Million	-439,433 Reduced 74.24%	152,500 $1.04 Million
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $36,786 - $83,626	-24,524 Reduced 3.98%	591,933 $1.5 Million
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $458,909 - $796,787	-252,148 Reduced 29.03%	616,457 $1.48 Million
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $92,475 - $230,750	29,172 Added 3.48%	868,605 $2.95 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $250,414 - $450,064	34,070 Added 4.23%	839,433 $6.17 Million
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $4.23 Million - $8.84 Million	542,363 Added 206.22%	805,363 $8.34 Million
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $55,000 - $107,250	-5,000 Reduced 1.87%	263,000 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $301,350 - $537,000	15,000 Added 5.93%	268,000 $5.63 Million
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $6.94 Million - $11 Million	253,000 New	253,000 $7.85 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $343,107 - $395,702	-6,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $316,680 - $446,160	-7,800 Reduced 53.79%	6,700 $350,000
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $31,936 - $43,088	800 Added 5.84%	14,500 $701,000
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $144,690 - $198,480	3,000 Added 28.04%	13,700 $692,000
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $127,949 - $168,452	-2,300 Reduced 17.69%	10,700 $634,000
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $72,495 - $83,460	-1,500 Reduced 10.34%	13,000 $656,000
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $91,102 - $111,499	-2,050 Reduced 12.39%	14,500 $763,000
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $54,766 - $69,237	-1,450 Reduced 8.06%	16,550 $769,000
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $614,520 - $728,100	18,000	18,000 $728,000

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Emergent Bio Solutions Inc. Transaction History